21
Views
266
CrossRef citations to date
0
Altmetric
Research Article

DOCK180, a Major CRK-Binding Protein, Alters Cell Morphology upon Translocation to the Cell Membrane

, , , , , , & show all
Pages 1770-1776 | Received 15 Aug 1995, Accepted 26 Jan 1996, Published online: 29 Mar 2023

REFERENCES

  • Aronheim, A., D. Engelberg, N. X. Li, N. Alalawi, J. Schlessinger, and M. Karin. 1994. Membrane targeting of the nucleotide exchange factor sos is sufficient for activating the ras signaling pathway. Cell 78:949–961.
  • Birge, R. B., J. E. Fajardo, B. J. Mayer, and H. Hanafusa. 1992. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze crk-phosphotyrosine-dependent interactions in vitro. J. Biol. Chem. 267:10588–10595.
  • Birge, R. B., J. E. Fajardo, C. Reichman, S. E. Shoelson, Z. Songyang, L. C. Cantley, and H. Hanafusa. 1993. Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts. Mol. Cell. Biol. 13:4648–4656.
  • Clark, E. A., and J. S. Brugge. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233–239.
  • Cohen, G. B., R. Ren, and D. Baltimore. 1995. Modular binding domains in signal transduction proteins. Cell 80:237–248.
  • Feig, L. A., and B. Schaffhausen. 1994. Signal transduction—the hunt for ras targets. Nature (London) 370:508–509.
  • Feller, S. M., B. Knudsen, and H. Hanafusa. 1995. Cellular proteins binding to the first src homology 3 (SH3) domain of the proto-oncogene product c-crk indicate crk-specific signaling pathways. Oncogene 10:1465–1473.
  • Feller, S. M., R. B. Ren, H. Hanafusa, and D. Baltimore. 1994. SH2 and SH3 domains as molecular adhesives: the interactions of crk and abl. Trends Biochem. Sci. 19:453–458.
  • Gotoh, N., A. Tojo, K. Muroya, Y. Hashimoto, S. Hattori, S. Nakamura, T. Takenawa, Y. Yazaki, and M. Shibuya. 1994. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity. Proc. Natl. Acad. Sci. USA 91:167–171.
  • Gotoh, T., S. Hattori, S. Nakamura, H. Kitayama, M. Noda, Y. Takai, K. Kaibuchi, H. Matsui, O. Hatase, H. Takahashi, T. Kurata, and M. Matsuda. 1995. Identification of Rap1 as a target for Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol. 15:6746–6753.
  • Gout, I., R. Dhand, I. D. Hiles, M. J. Fry, G. Panayotou, P. Das, O. Truong, N. F. Totty, J. Hsuan, G. W. Booker, I. D. Campbell, and M. D. Waterfield. 1993. The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell 75:25–36.
  • Hasegawa, H., E. Kiyokawa, and M. Matsuda. Unpublished results.
  • Hempstead, B. L., R. B. Birge, J. E. Fajardo, R. Glassman, D. Mahadeo, R. Kraemer, and H. Hanafusa. 1994. Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor-and epidermal growth factor-dependent pathways. Mol. Cell. Biol. 14:1964–1971.
  • Higgins, D. G., and P. M. Sharp. 1988. CLUSTAL: a package for performing multiple sequence alignments on a microcomputer. Gene 73:237–244.
  • Holsinger, L. J., D. M. Spencer, D. J. Austin, S. L. Schreiber, and G. R. Crabtree. 1995. Signal transduction in T lymphocytes using a conditional allele of sos. Proc. Natl. Acad. Sci. USA 92:9810–9814.
  • Juliano, R. L., and S. Haskill. 1993. Signal transduction from the extracellular matrix. J. Cell Biol. 120:577–585.
  • Knudsen, B. S., S. M. Feller, and H. Hanafusa. 1994. Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first src homology 3 domain of Crk. J. Biol. Chem. 269:32781–32787.
  • Knudsen, B. S., J. Zheng, S. M. Feller, J. P. Mayer, S. K. Burrell, D. Dowburn, and H. Hanafusa. 1995. Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins. EMBO J. 14:2191–2198.
  • Kozak, M. 1991. An analysis of vertebrate messenger RNA sequences— initiations of translational control. J. Cell Biol. 115:887–903.
  • Matsuda, M., Y. Hashimoto, K. Muroya, H. Hasegawa, T. Kurata, S. Tanaka, S. Nakamura, and S. Hattori. 1994. CRK binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol. Cell. Biol. 14:5495–5500.
  • Matsuda, M., B. J. Mayer, Y. Fukui, and H. Hanafusa. 1990. Binding of oncoprotein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins. Science 248:1537–1539.
  • Matsuda, M., S. Tanaka, S. Nagata, A. Kojima, T. Kurata, and M. Shibuya. 1992. Two species of human CRK cDNA encode proteins with distinct biological activities. Mol. Cell. Biol. 12:3482–3489.
  • Matuoka, K., M. Shibata, A. Yamakawa, and T. Takenawa. 1992. Cloning of ASH, a ubiquitous protein composed of one Src homology region (SH)-2 and 2 SH3 domains, from human and rat cDNA libraries. Proc. Natl. Acad. Sci. USA 89:9015–9019.
  • Mayer, B. J., M. Hamaguchi, and H. Hanafusa. 1988. A novel viral oncogene with structural similarity to phospholipase C. Nature (London) 332:272–275.
  • Mayer, B. J., and H. Hanafusa. 1990. Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation. J. Virol. 64:3581–3589.
  • Mayer, B. J., and H. Hanafusa. 1990. Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity. Proc. Natl. Acad. Sci. USA 87:2638–2642.
  • McCoy, M. S., C. I. Bargmann, and R. A. Weinberg. 1984. Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-oncogene. Mol. Cell. Biol. 4:1577–1582.
  • Miki, H., K. Miura, K. Matuoka, T. Nakata, N. Hirokawa, S. Orita, R. Kaibuchi, Y. Takai, and T. Takenawa. 1994. Association of Ash/Grb-2 with dynamin through the SRC homology 3 domain. J. Biol. Chem. 269:5489–5492.
  • Musacchio, A., M. Wilmanns, and M. Saraste. 1994. Structure and function of the SH3 domain. Prog. Biophys. Mol. Biol. 61:283–297.
  • Niwa, H., K. Yamamura, and J. Miyazaki. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193–200.
  • Nojima, Y., N. Morino, T. Mimura, K. Hamasaki, H. Furuya, R. Sakai, T. Sato, K. Tachibana, C. Morimoto, Y. Yazaki, and H. Hirai. 1995. Integrinmediated cell adhesion promotes tyrosine phosphorylation of p130(cas), a src homology 3-containing molecule having multiple src homology 2-binding motifs. J. Biol. Chem. 270:15398–15402.
  • Odai, H., K. Sasaki, A. Iwamatsu, Y. Hanazono, T. Tanaka, K. Mitani, Y. Yazaki, and H. Hirai. 1995. The proto-oncogene product c-cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. J. Biol. Chem. 270:10800–10805.
  • Ogawa, S., H. Toyoshima, H. Kozutsumi, K. Hagiwara, R. Sakai, T. Tanaka, N. Hirano, H. Mano, Y. Yazaki, and H. Hirai. 1994. The c-terminal SH3 domain of the mouse c-crk protein negatively regulates tyrosine-phosphorylation of crk associated p130 in rat 3Y1 cells. Oncogene 9:1669–1678.
  • Pawson, T. 1995. Protein modules and signalling networks. Nature (London) 373:573–580.
  • Quilliam, L. A., S. Y. Huff, K. M. Rabun, W. Wei, W. Park, D. Broek, and C. J. Der. 1994. Membrane-targeting potentiates guanine nucleotide exchange factor CDC25 and SOS1 activation of ras transforming activity. Proc. Natl. Acad. Sci. USA 91:8512–8516.
  • Reichman, C. T., B. J. Mayer, S. Keshau, and H. Hanafusa. 1992. The product of the cellular crk gene consists primarily of SH2 and SH3 regions. Cell Growth Differ. 3:451–460.
  • Richardson, A., and J. T. Parsons. 1995. Signal transduction through inte-grins: a central role for focal adhesion kinase? Bioessays 17:229–236.
  • Sakai, R., A. Iwamatsu, N. Hirano, S. Ogawa, T. Tanaka, H. Mano, Y. Yazaki, and H. Hirai. 1994. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 13:3748–3756.
  • Sawasdikosol, S., K. S. Ravichandran, K. K. Lee, J.-H. Chang, and S. J. Burakoff. 1995. Crk interacts with tyrosine-phosphorylated p116 upon T cell activation. J. Biol. Chem. 270:2893–2896.
  • Schaller, M. D., and J. T. Parsons. 1994. Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol. 6:705–710.
  • Schaller, M. D., and J. T. Parsons. 1995. pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk. Mol. Cell. Biol. 15:2635–2645.
  • Schlaepfer, D. D., S. K. Hanks, T. Hunter, and P. Vandergeer. 1994. Inte-grin-mediated signal transduction linked to ras pathway by GRB2 binding to focal adhesion kinase. Nature (London) 372:786–791.
  • Schumacher, C., B. S. Knudsen, T. Ohuchi, P. P. Difiore, R. H. Glassman, and H. Hanafusa. 1995. The SH3 domain of crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R. J. Biol. Chem. 270:15341–15347.
  • Tanaka, S., S. Hattori, T. Kurata, K. Nagashima, Y. Fukui, S. Nakamura, and M. Matsuda. 1993. Requirement of both the SH2 and SH3 domains for neuronal differentiation of PC12 cells induced by human CRK protein. Mol. Cell. Biol. 13:4409–4415.
  • Tanaka, S., T. Morishita, Y. Hashimoto, S. Hattori, S. Nakamura, T. Takenawa, K. Matuoka, M. Shibuya, T. Kurata, K. Nagashima, and M. Mat-suda. 1994. C3G, a guanine nucleotide releasing protein, binds to the SH3 domains of CRK and ASH/GRB2. Proc. Natl. Acad. Sci. USA 91:3443–3447.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.